The Study of the efficacy, safety and tolerability of low molecular weight heparin vs. unfractionated heparin in patients with embolic stroke due to atrial fibrillation
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2018
Price : $35 *
At a glance
- Drugs Enoxaparin sodium (Primary) ; Heparin; Warfarin
- Indications Stroke; Thromboembolism
- Focus Therapeutic Use
- 22 Feb 2018 Status changed from recruiting to completed.
- 22 Mar 2014 Recruitment is expected to complete on 01 Feb 2016, as per Iranian Registry of Clinical Trials record.
- 22 Mar 2014 New trial record